Other Private Equity/Strategic Investments
Piramal Pharma invests Rs.102-Cr in Yapan Bio
Piramal Pharma Solutions (PPS) has picked up a significant minority stake of 27.78% in Hyderabad based Contract Development and Manufacturing Organization (CDMO) Yapan Bio Pvt Ltd for an investment of INR 101.77 crore. The investment in Yapan Bio allows PPS to broaden its service offerings in the fast-growing biologics CDMO space. Yapan Bio provides process development, scale-up, and current good manufacturing practice (cGMP) compliant manufacturing of vaccines and biologics, including high containment product classes (up to BSL-2+), recombinant vaccines, RNA/DNA vaccines, gene therapies, monoclonal antibodies, therapeutic proteins, and other complex biologics. Yapan had reported a turnover of INR 12.4 crore for FY21.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
